Expert Directory

Zachariah DeFilipp, MD

Attending Physician, Hematopoietic Cell Transplant and Cell Therapy Program

Director of BMT Clinical Research

Massachusetts General Hospital Cancer Center

Associate Professor of Medicine

Harvard Medical School

Boston, MA

Zachariah DeFilipp, MD, is an attending physician in the Hematopoietic Cell Transplant and Cell Therapy Program and director of BMT Clinical Research at the Massachusetts General Hospital Cancer Center. He is also an associate professor of medicine at Harvard Medical School.

Dr DeFilipp is actively involved in translational and clinical research initiatives to improve outcomes for patients undergoing allogeneic hematopoietic cell transplantation. His research has primarily focused on the development of approaches to the prevention and treatment of graft-versus-host disease.

Contributing Articles

Chronic Graft-versus-Host Disease

Chronic Graft-versus-Host Disease: Integrating Patient-Reported Outcomes Into Response Assessment

expert roundtables
By Corey Cutler, MD, MPH, FRCP(C); Zachariah DeFilipp, MD; Miguel-Angel Perales, MD

$New Horizons for the Treatment of Refractory Chronic Graft-versus-Host Disease$

Chronic Graft-versus-Host Disease

New Horizons for the Treatment of Refractory Chronic Graft-versus-Host Disease

expert roundtables
By Corey Cutler, MD, MPH, FRCP(C); Zachariah DeFilipp, MD; Miguel-Angel Perales, MD

Chronic Graft-versus-Host Disease

Multidisciplinary, Integrated Care for Patients With Chronic Graft-versus-Host Disease

expert roundtables
By Corey Cutler, MD, MPH, FRCP(C); Zachariah DeFilipp, MD; Miguel-Angel Perales, MD

Chronic Graft-versus-Host Disease

Expert Roundtables Podcast: Advances in Graft-versus-Host Disease Prophylaxis and Prevention

expert roundtables
By Corey Cutler, MD, MPH, FRCP(C); Zachariah DeFilipp, MD; Miguel-Angel Perales, MD

$Ongoing Research Into Combination Targeted Therapy for Refractory Chronic Graft-versus-Host Disease$

Chronic Graft-versus-Host Disease

Ongoing Research Into Combination Targeted Therapy for Refractory Chronic Graft-versus-Host Disease

clinical topic updates
By Zachariah DeFilipp, MD